Plasma levels of CTSB increased after adults at high risk for AD participated in 26 weeks of moderate-to-vigorous intensity cardiovascular exercise, with this alteration in CTSB positively correlated with cognitive performance (Gaitán et al., 2021). This evidence concerns the gene CTSB and Alzheimer disease.